<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Stub><StubValue>NCI-CTC toxicity grade</StubValue></Stub><HeaderValue>Dose of irinotecan (mg m−2) 100</HeaderValue></NavigationPath><value>4</value><CellType>Numeric</CellType></Cell><Table><tableName>Worst toxicity per patient (all cycles) by irinotecan dose level considered related to irinotecan in combination with continuous infusion 5-FU</tableName><TableType>Subheader</TableType><tableOrder>Table 3</tableOrder><tableFooter>NCI-CTC=National Cancer Institute-Common Toxicity Criteria; ALP=alkaline phosphatase; HFS=hand-foot syndrome.aRelated to 5-FU infusion.bSix patients had grade 1 HFS.c11 patients had grade 1 nausea.</tableFooter></Table><Document><DocumentTitle>Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer</DocumentTitle><PMC>2409945</PMC></Document></information>